Online Spanish Cognitive Intervention Program for Spanish-Speaking Latino/Hispanic Subarachnoid Hemorrhage Patients

DHR Health

Status: Withdrawn

Conditions: Subarachnoid Hemorrhage; Cognitive Impairment; Quality of Life; Depression, Anxiety

Treatments: Device: brainHQ by Posit Science

Study type: Interventional

Funder types: Other

Identifiers

NCT03621397

1222300-1

Details and patient eligibility

About

The purpose of this research study is to examine the effectiveness of an online Spanish cognitive intervention program in Latino/Hispanic Spanish-speaking subarachnoid hemorrhage patients. In particular, the researchers will examine whether cognitive impairments associated with a subarachnoid hemorrhagic event improve after completing the online cognitive intervention program. Secondary outcomes of the research study include examining whether there is an improvement in research participants' quality of life and psychological functioning as a result of the online Spanish cognitive intervention program.

Full description

40 Spanish-speaking research participants who have sustained a subarachnoid hemorrhage in the last 6 months will participate in the current research study. Participants will be randomly assigned to one of two groups: 1) Cognitive intervention group (n = 20) or 2) Control group (n = 20).

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• History of a subarachnoid hemorrhage within the last 6-months. Must be confirmed by medical records and/or neurointerventionist radiologist
• 18 years and older
• Primarily Spanish-Speaking
• Able to read in Spanish
• Able to use a computer

Exclusion criteria

• History of neurological conditions (e.g., Alzheimer's disease, epilepsy, traumatic brain injury, brain tumor, encephalitis, meningitis, Parkinson's disease) other than subarachnoid hemorrhage
• History of neurodevelopment disorder (e.g., autism spectrum disorders, attention deficit-hyperactivity disorder)
• History of learning disabilities
• History of psychiatric illness (e.g., depression, anxiety, bipolar disorder, schizophrenia)
• Alcohol or illicit substance abuse or dependence
• Currently on medication(s) that may impact performance on the neuropsychological evaluation or online cognitive intervention program
• Severe expressive aphasia
• Upper extremities or vision problems that prevent participant from adequately using a computer or completing the neuropsychological evaluation
• Unable to commit to participate for the entire study including returning for one-year follow-up neuropsychological evaluation

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

Cognitive Intervention Group

Experimental group

Description:

Research participants in the cognitive intervention group will undergo a baseline neuropsychological evaluation. One week later, they will receive the online training program (brainHQ by Posit Science) three times a week for 45 minutes for a total of 12 weeks. This group will return one week after completing the online intervention program for their follow-up neuropsychological evaluation. They will then return again one year later for another follow-up neuropsychological evaluation.

Treatment:

Device: brainHQ by Posit Science

Control Group

No Intervention group

Description:

Research participants in the control group will undergo a baseline neuropsychological evaluation. They will then return 13 weeks after their baseline neuropsychological evaluation for a follow-up neuropsychological evaluation and again one year later.